Email This Article

Headlines & Perspectives
Health Winners & Losers: Invitrogen
By Elizabeth Trotta
07/08/08 - 05:41 PM EDT
Invitrogen and ViroPharma climb on regulatory news.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,284.15 1,092.27 2,175.19 33.92
Oil *
75.33
DOWN
105.96
DOWN
10.98
DOWN
14.42
DOWN
0.56
10 Yr
3.39%
SPDR Gold
110.50
-1.02%
-1.00%
-0.66%
-1.62%
Data delayed 20 minutes

Brokerage Partners